Rightmove Rewarded by Tough Housing Market: The London Rush
Hi, I’m Leo from Bloomberg’s UK Breaking News team, catching you up on this morning’s business stories. There’s
2023-11-27 16:52
GSK’s Nigerian Unit to Close Down, Return Cash
GlaxoSmithKline Consumer Nigeria Plc, the second-biggest drug firm in the West African nation, will cease operations after its
2023-08-04 16:51
GSK sues Pfizer in US for patent infringement over RSV vaccine
By Blake Brittain (Reuters) -British biopharmaceutical giant GSK sued Pfizer in a U.S. court on Wednesday, alleging that Pfizer's respiratory
2023-08-02 22:20
GSK reaches settlement in US Zantac litigation
(Reuters) -GSK Plc on Friday said it reached a confidential settlement of a litigation in the United States over claims
2023-06-23 14:21
GSK's RSV vaccine shows long-term efficacy in late-stage trial
(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong
2023-06-21 14:48
EU approves its first vaccine for common respiratory virus RSV
By Natalie Grover and Eva Mathews (Reuters) -European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV),
2023-06-07 16:17
GSK's cancer drug Jemperli gets file acceptance from US FDA
GSK said on Tuesday that the U.S. Food and Drug Administration had granted file acceptance for its cancer
2023-06-06 15:16